Literature DB >> 11828325

Structural basis for CDK6 activation by a virus-encoded cyclin.

Ursula Schulze-Gahmen1, Sung-Hou Kim.   

Abstract

Cyclin from herpesvirus saimiri (Vcyclin) preferentially forms complexes with cyclin-dependent kinase 6 (CDK6) from primate host cells. These complexes show higher kinase activity than host cell CDKs in complex with cellular cyclins and are resistant to cyclin-dependent inhibitory proteins (CDKIs). The crystal structure of human CDK6--Vcyclin in an active state was determined to 3.1 A resolution to better understand the structural basis of CDK6 activation by viral cyclins. The unphosphorylated CDK6 in complex with Vcyclin has many features characteristic of cyclinA-activated, phosphorylated CDK2. There are, however, differences in the conformation at the tip of the T-loop and its interactions with Vcyclin. Residues in the N-terminal extension of Vcyclin wrap around the tip of the CDK6 T-loop and form a short beta-sheet with the T-loop backbone. These interactions lead to a 20% larger buried surface in the CDK6--Vcyclin interface than in the CDK2--cyclinA complex and are probably largely responsible for the specificity of Vcyclin for CDK6 and resistance of the complex to inhibition by INK-type CDKIs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828325     DOI: 10.1038/nsb756

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  20 in total

Review 1.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

3.  Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition.

Authors:  Maria Emanuela Cuomo; Georgina M Platt; Laurence H Pearl; Sibylle Mittnacht
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

4.  CDK6 kinase activity is required for thymocyte development.

Authors:  Miaofen G Hu; Amit Deshpande; Nicolette Schlichting; Elisabeth A Hinds; Changchuin Mao; Marei Dose; Guo-Fu Hu; Richard A Van Etten; Fotini Gounari; Philip W Hinds
Journal:  Blood       Date:  2011-04-20       Impact factor: 22.113

5.  Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9.

Authors:  Kyuwon Baek; Raymond S Brown; Gabriel Birrane; John A A Ladias
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

6.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 7.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 8.  Structure-based discovery of cyclin-dependent protein kinase inhibitors.

Authors:  Mathew P Martin; Jane A Endicott; Martin E M Noble
Journal:  Essays Biochem       Date:  2017-11-08       Impact factor: 8.000

9.  Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer.

Authors:  Zhen Xing; Yanyan Zhang; Ke Liang; Liang Yan; Yu Xiang; Chunlai Li; Qingsong Hu; Feng Jin; Vasanta Putluri; Nagireddy Putluri; Cristian Coarfa; Arun Sreekumar; Peter K Park; Tina K Nguyen; Shouyu Wang; Jianwei Zhou; Yan Zhou; Jeffrey R Marks; David H Hawke; Mien-Chie Hung; Liuqing Yang; Leng Han; Haoqiang Ying; Chunru Lin
Journal:  Cancer Res       Date:  2018-07-02       Impact factor: 12.701

10.  Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat.

Authors:  Kanchan Anand; Antje Schulte; Koh Fujinaga; Klaus Scheffzek; Matthias Geyer
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.